Filippo Mazzi

Verona, 37134, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Colchicine Protects Against Sickle Cell Related Cardiomyopathy: Evidence of the Novel Role of Inflammaging.

Colchicine Protects Against Sickle Cell Related Cardiomyopathy: Evidence of the Novel Role of Inflammaging.

Journal: Antioxidants (Basel, Switzerland)
Published: May 18, 2026

Hematopoietic Stem Cell Transplantation for Hyperhemolytic Syndrome.

Hematopoietic Stem Cell Transplantation for Hyperhemolytic Syndrome.

Journal: Pediatric blood & cancer
Published: February 05, 2026

Exercise reveals precocious-subclinical cardiovascular and muscular dysfunction in transfusion dependent beta-thalassemia (TDT) patients without cardiac iron overload.

Exercise reveals precocious-subclinical cardiovascular and muscular dysfunction in transfusion dependent beta-thalassemia (TDT) patients without cardiac iron overload.

Journal: Journal of translational medicine
Published: October 29, 2025

Atrial fibrillation prevalence and its management in aging transfusion-dependent thalassemia patients: the FATHAL study.

Atrial fibrillation prevalence and its management in aging transfusion-dependent thalassemia patients: the FATHAL study.

Journal: Blood advances
Published: June 26, 2025

Atrial fibrillation prevalence and its management in aging, transfusion-dependent patients with thalassemia: the FATHAL study.

Atrial fibrillation prevalence and its management in aging, transfusion-dependent patients with thalassemia: the FATHAL study.

Journal: Blood advances
Published: June 26, 2025

Intravenous immunoglobulins in the management of acute chest syndrome in two Jehovah's Witnesses with sickle cell disease.

Intravenous immunoglobulins in the management of acute chest syndrome in two Jehovah's Witnesses with sickle cell disease.

Journal: Haematologica
Published: April 15, 2025

Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders.

Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders.

Journal: Blood
Published: December 22, 2023

Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease.

Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease.

Journal: Haematologica
Published: August 11, 2023

Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease.

Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease.

Journal: Orphanet journal of rare diseases
Published: June 26, 2023

Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients.

Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients.

Journal: American journal of hematology
Published: February 14, 2023

Impaired pro-resolving mechanisms promote abnormal NETosis, fueling autoimmunity in sickle cell disease.

Impaired pro-resolving mechanisms promote abnormal NETosis, fueling autoimmunity in sickle cell disease.

Journal: American journal of hematology
Published: November 14, 2022

High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis.

High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis.

Journal: Diagnostics (Basel, Switzerland)
Published: September 09, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026